AIMed conference in artificial intelligence in cardiology, medical imaging.

The integration of artificial intelligence (AI) into medicine has by far been the hottest topic at nearly all medical conferences for radiology, cardiology and several other subspecialties over the past two years. This has led to the creation of an organization AIMed to help spearhead collaboration and dissemination of information on AI developments to speed its adoption. 

Catheter Interventions in Congenital, Structural and Valvular Heart Disease (CSI)

Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.

Spacelabs Healthcare debuted Sentinel 11 at the 40th Annual Heart Rhythm Society (HRS) Scientific Sessions, May 8-11, 2019, in San Francisco. This latest release from Spacelabs advances cardiology information management with optimized workflows, expanded connectivity and robust data security capabilities.

EuroPCR 2019 Hot Line Late Breaking trial presentations.

May 10, 2019 — Here is the list of the late-breaking hot line studies being presented at the 2019 EuroPCR interventional cardiology meeting, May 21-24, in Paris, France.

EuroPCR 2019 Hot Line and Trial Update
Tuesday May 21, 12:00 - 13:15, Main Arena, Level 1
   • Mitral regurgitation after MitraClip implantation: relationship between residual mitral regurgitation and clinical and functional outcomes from the COAPT trial. Presented by S. Kar.

May 10, 2019 — Diagnostic and Interventional Cardiology (DAIC) earned a Bronze Award at the 2019 National Azbee Awards of Excellence in the Social Media Presence category for reaching more than 100,000 people every month on social media in 2018.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation, in green. The blue shows critical structures in the area around the heart that should be avoided by the radiation beam.

May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has developed technology to use radiation therapy in the heart (cardiac radio-ablation) and other forms of radiosurgery for cardiovascular disease. This technology signals the company's entry into cardiology with a first of its kind technology that could represent a pardigm shift in electrophysiology (EP) ablation procedures. 

International Symposium for Applied Cardiovascular Biology and Vascular Tissue Engineering

Multi-Level CTO Course 2019

The recanalization of coronary chronic total occlusion (CTO) has become an important procedure to treat symptomatic patients with ischemia or heart failure.. It is a growing and constantly evolving discipline, allowing us to improve our daily practice in percutaneous coronary interventions (PCI). Learning or reviewing the basics, tips & tricks, and mastering CTO techniques is essential to manage complex coronary patients. More and more interventional cardiologists are eager to learn and develop CTO PCI programs in their CathLabs.

Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety and performance of the DyeVert Contrast Reduction System during standard clinical use in a real-world patient population. The DyeMINISH registry is a retrospective, large-scale, multi-center study, with the first patient included on May 7, 2019. The registry is designed to enroll up to 10,000 participants and is expected to complete in late 2023.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now